Determination of clozapine and its metabolite, N-desmethylclozapine, in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats

J Chromatogr B Biomed Sci Appl. 1998 Aug 7;712(1-2):193-8. doi: 10.1016/s0378-4347(98)00148-0.

Abstract

A single solvent extraction step high-performance liquid chromatographic method is described for quantitating clozapine and its metabolite, N-desmethylclozapine, in rat serum microsamples (50 microl). The separation used a 2.1-mm I.D. reversed-phase Symmetry C18 column with an isocratic mobile phase consisting of methanol-acetonitrile-28.6 mM sodium acetate buffer, pH 2.6 (10:20:70, v/v/v). The detection limit was 2.5 ng/ml for all the compounds using an ultraviolet detector operated at 230 nm. The method was used to study the pharmacokinetics of clozapine after an intravenous bolus dose (2.5 mg/kg).

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / blood*
  • Antipsychotic Agents / pharmacokinetics
  • Chromatography, High Pressure Liquid
  • Clozapine / administration & dosage
  • Clozapine / analogs & derivatives*
  • Clozapine / blood*
  • Clozapine / pharmacokinetics
  • Injections, Intravenous
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Sensitivity and Specificity

Substances

  • Antipsychotic Agents
  • norclozapine
  • Clozapine